Websites using strategic clinical innovation as a keyword

NUS Synthetic Biology for Clinical and Technological Innovation (SynCTI) was formally established in 2014 as the focal research program for Synthetic Biology at the National University of Singapore. SynCTI operates as a highly interdisciplinary research core that amalgamates researchers from multiple disciplinary fields, and closely interacts with other research programs within NUS, leveraging on existing research capabilities in synthetic biology that have been developed through funding from local and international organizations. At its initiation, SynCTI will focus on three strategic research thrusts that represent foundational aspects of synthetic biology, and present significant opportunities to advance knowledge and core enabling technologies in synthetic biology

Clinical and regulatory consultant that helps pharma/biotech companies simplify clinical research, streamlined protocols, and achieve cost-effective trials.

Our aim is to facilitate business creation and growth and accelerate clinical innovation adoption, bringing better health and wealth to our region

SPRIM, a globally integrated health science consulting firm with experience in building marketing communication programs for brands in the health and medical space.

Innoviss is a privately held financially strong company with over 30 years experience preserving our national security Innoviss brings together an experienced and proven leadership team recognized for performance and delivery Innoviss is headquartered in Chevy Chase MD with two subsidiaries MSM Security Services and AIM Healthcare Solutions